Kali Inc is a pharmaceutical company. The Company research and development of treatments for various illnesses, diseases and chronic pain as a symptom of various diagnoses. It also concentrates on the development of health and wellness therapies.

Employees

Sector

Pharmaceuticals

More about the company

20-07-29	PAO Group, Inc. completed the acquisition of NCM Biotech from Kali, Inc..	CI
20-07-15	PAO Group, Inc. agreed to acquire NCM Biotech from Kali, Inc..	CI

Market Cap	1.98M 1.69M 1.58M 1.45M 2.72M 189M 2.76M 18.72M 7.3M 95.03M 7.43M 7.27M 314M	P/E 2011	2.66x	P/E 2012	0.55x
Enterprise Value	-24.94M -21.36M -19.98M -18.29M -34.33M -2.39B -34.8M -236M -92M -1.2B -93.65M -91.61M -3.96B	EV / Sales 2011	0.24x	EV / Sales 2012	-0.18x
Free-Float	98.86%	Yield 2011 *	-	Yield 2012	-

20-07-29	PAO Group, Inc. completed the acquisition of NCM Biotech from Kali, Inc..	CI
20-07-15	PAO Group, Inc. agreed to acquire NCM Biotech from Kali, Inc..	CI
20-03-12	Puration, Inc. completed the acquisition of Hemp4mula CBD Confections operations of Kali, Inc..	CI
20-03-02	Kali-Extracts, Inc. Evaluates Patented Cannabis Extract for Potential Coronavirus Treatment	CI
20-02-11	Puration, Inc. made a proposal to acquire Hemp4mula CBD Confections operations of Kali, Inc..	CI
20-02-03	Kali, Inc. announced that it expects to receive $20 million in funding	CI
20-01-24	KALY Enters into Discussions with Puration Regarding Pura's Possible Acquisition of KALY's CBD Confection Assets	CI
19-11-26	Kali-Extracts, Inc. Reports Sales Results for the Three Months and Year to Date Ended September 30, 2019; Provides Sales Guidance for the Year 2019	CI
19-11-05	Kali-Extracts, Inc. Announces Plans to Introduce USDA Organic CBD Oil and USDA Organic CBD Infused Beverages	CI
19-10-30	Kali-Extracts Announces Third CBD Extraction Agreement Adding to $15 Million in Current Contracts	CI
19-10-30	Kali Extracts Announces USDA Organic Certification for First Hemp Crop	CI
19-10-23	Kali-Extracts, Inc. Announces New CBD Hemp4mula Gummies Now Available on USMJ.com	CI
19-10-11	Kali-Extracts Is Making CBD Infused Coffee	CI

21-05-19	Alkame : PAO Group, Inc. Expands Its CBD Nutraceuticals Program; Three Products By EOY 2021 Targets $5 Billion Global Demand	AQ
21-05-12	Alkame : PAO Group, Inc.'s CBD Nutraceuticals Expected To Deliver Revenue-Generating Catalyst in 2021; New Partnerships Expand Its Long-Term CBD Pharmaceutical Programs	AQ
21-05-06	PAO Group, With A CRO On Its Side, Could Deliver Its First CBD-Based Therapeutic By Year's End	AQ
21-04-13	Kali : PAO Group, Inc. Rallies 21% On Monday; Investor Update This Morning Adds Fuel To Bullish Sentiment	AQ
21-04-13	PAOG Announces Opportunity To Expand CBD Pharmaceutical Research	NE

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	+0.88%	+3.84%	+77.96%	+129.75%	1,109B
JOHNSON & JOHNSON	+1.07%	+3.11%	+51.11%	+56.67%	644B
ABBVIE INC.	+1.20%	+5.64%	+26.68%	+76.48%	463B
ROCHE HOLDING AG	+1.02%	+3.67%	+43.14%	+47.27%	371B
NOVARTIS AG	+0.85%	+2.97%	+24.48%	+42.54%	301B
ASTRAZENECA PLC	+1.26%	+4.54%	+2.20%	+14.84%	256B
AMGEN INC.	+1.88%	+5.14%	+48.20%	+67.80%	234B
NOVO NORDISK A/S	+1.59%	+0.87%	-12.95%	-51.91%	205B
GILEAD SCIENCES, INC.	+1.87%	+5.78%	+23.07%	+92.57%	178B
Average	+1.10%	+3.00%	+31.54%	+52.89%	417.9B
Weighted average by Cap.	+0.73%	+3.26%	+44.79%	+72.24%

Kali Inc Stock OTC Bulletin Board

Stocks

Pharmaceuticals

Valuation: Kali Inc

Latest news : Kali Inc

Analysts' recommendations: Kali Inc

Press Releases: Kali Inc

Other Pharmaceuticals

Financials

Company Profile

	2011	2012
Net sales	88.83M 76.06M 71.14M 65.12M 122M 8.5B 124M 840M 328M 4.27B 333M 326M 14.11B	94.55M 80.96M 75.72M 69.32M 130M 9.05B 132M 895M 349M 4.54B 355M 347M 15.02B
Net income	13.93M 11.93M 11.15M 10.21M 19.17M 1.33B 19.43M 132M 51.37M 669M 52.29M 51.15M 2.21B	17.88M 15.31M 14.32M 13.11M 24.61M 1.71B 24.94M 169M 65.94M 859M 67.12M 65.66M 2.84B
Net Debt	-14.72M -12.61M -11.79M -10.8M -20.27M -1.41B -20.54M -139M -54.31M -707M -55.29M -54.08M -2.34B	-26.92M -23.05M -21.56M -19.74M -37.05M -2.58B -37.55M -255M -99.3M -1.29B -101M -98.87M -4.28B

End-of-day quote OTC Bulletin Board
- ^USD	-